Experian Health’s 2025 State of Claims survey shows rising denial rates, data errors, and low artificial intelligence adoption despite providers’ belief in its potential.
Christopher Gold, DO
Advertisement
Christopher Gold, DO, is an internal medicine physician at Mount Sinai in New York.
Articles by Christopher Gold, DO
As drug denials increase, experts discuss the importance of optimizing data to keep up with these changes and implementing artificial intelligence (AI) to reduce the burden on providers and ensure patient access to care and treatment.
Advertisement
Latest Updated Articles
AI Seen as Key to Reducing Health Care Claim Denials, Survey FindsSeptember 30th 2025
Advertisement
Advertisement
Trending on AJMC
1
FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301
2
New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease
3
Andes Hantavirus FAQs: What to Know as Quarantined Cruise Passengers Return Home
4
Cancer’s Hidden Wound: Trauma From Diagnosis Through Survivorship
5